Farallon Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-47,000
Closed -$15.1M 152
2024
Q3
$15.1M Sell
47,000
-185,000
-80% -$60.5M 0.07% 85
2024
Q2
$72.5M Buy
+232,000
New +$68.2M 0.31% 54
2013
Q4
Sell
-88,000
Closed -$9.85M 80
2013
Q3
$9.85M Buy
+88,000
New +$9.54M 0.2% 55

Other funds holding AMGN

Farallon Capital Management's AMGN Position: Q4 2024 in Review

Farallon Capital Management sold out of Amgen (AMGN) in Q4 2024, closing a stake of 47,000 shares — an estimated $15.1M sold.

Farallon Capital Management first reported a position in AMGN in Q3 2013 and held it in 3 quarters. The position peaked at $72.5M in Q2 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Farallon Capital Management reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Farallon Capital Management sold 47,000 Amgen shares in Q4 2024, an estimated $15.1M.
  • Farallon Capital Management first reported a position in Amgen in Q3 2013 and held it in 3 quarters.
  • Farallon Capital Management's Amgen position peaked at $72.5M in Q2 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Farallon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.